objective to determine the effect of fibre antispasmodics and peppermint oil in the treatment of irritable bowel syndromedesign systematic review and metaanalysis of randomised controlled trialsdata sources medline embase and the cochrane controlled trials register up to april 2008 review methods randomised controlled trials comparing fibre antispasmodics and peppermint oil with placebo or no treatment in adults with irritable bowel syndrome were eligible for inclusionthe minimum duration of therapy considered was one week and studies had to report either a global assessment of cure or improvement in symptoms or cure of or improvement in abdominal pain after treatmenta random effects model was used to pool data on symptoms and the effect of therapy compared with placebo or no treatment was reported as the relative risk 95 confidence interval of symptoms persistingresults 12 studies compared fibre with placebo or no treatment in 591 patients relative risk of persistent symptoms 087 95 confidence interval 076 to 100this effect was limited to ispaghula 078 063 to 096twenty two trials compared antispasmodics with placebo in 1778 patients 068 057 to 081various antispasmodics were studied but otilonium four trials 435 patients relative risk of persistent symptoms 055 031 to 097 and hyoscine three trials 426 patients 063 051 to 078 showed consistent evidence of efficacyfour trials compared peppermint oil with placebo in 392 patients 043 032 to 059conclusion fibre antispasmodics and peppermint oil were all more effective than placebo in the treatment of irritable bowel syndrome